3879 results for «700»
3879 results
Complex and challenging cases II
19 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to discover how to safely manage difficult complications, thanks to a selection of complex clinical cases: ascending aortic dissection, balloon rupture, retrograde PCI on CTO of ostial right coronary artery, and more!
GulfPCR-GIM 2019 Award and Closing Ceremony
19 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to see the slides presented during GulfPCR-GIM 2019 Award and Closing Ceremony, which gathered 832 active participants, and discover who the best clinical case award winner was that year.
Clinical benefits of co-registration IVUS, FFR and iFR pullback in daily PCI
18 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to learn how to use IVUS to guide vessel preparation and size stents and assess angioplasty results, how SyncVision IVUS co-registration can improve efficiency of angioplasty, and how iFR co-registration can guide angioplasty in patients with diffuse disease.
Novel approach in the management of severely calcified lesions
19 Dec 2019 – From GulfPCR-GIM 2019
Consult this session dedicated to the Diamondback 360 coronary orbital atherectomy system to learn more about how this tool optimise the outcomes for coronary lesion preparation, how orbital atherectomy may fit into your daily practice, and what is the "must have" tool box for calcified coronary lesions.
PCI optimisation: OCT and physiology in a complex multivessel disease case
18 Dec 2019 – From GulfPCR-GIM 2019
The patient is a 57-year-old male with high-risk factors and previous history of revascularisation. He presents with ischemic chest pain with NSTE-ACS. The baseline angiography shows multivessel disease and calcified LAD/D1 bifurcation (1,1,0).
The key objectives of this case are:
- Utility of FFR in physiological assessment of a...
Updates in TAVI therapies
18 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to learn more about the latest updates in TAVI therapies, and discover the unique features of Acurate neo and Lotus Edge, the clinical evidence of both Boston Scientific TAVI platforms, while learning all about the needs of cerebral protection during TAVI procedures.
All you need to know to start optimising outcomes in PCI: OCT and physiology
19 Dec 2019 – From GulfPCR-GIM 2019
Consult this session on the new developments and future directions in functional coronary assessment to discover how and why physiology assessment/OCT could optimise procedural outcomes in PCI, and learn all about their main indications, the relevant indicators to be assessed, as well as the last changes...
Shaping the future of transcatheter valve interventions
19 Dec 2019 – From GulfPCR-GIM 2019
Consult this sesson to discover the future perspectives and innovations on transcatheter valve interventions, and learn of a new therapy in high surgical risk patients with the Tendyne clinical programme, which eliminates mitral regurgitation.
Left ventricular and systolic dimension determines anatomic suitability for transcatheter mitral valve implantation
25 Jun 2020 – From PCR e-Course 2020
A common exclusion for transcatheter mitral valve implantation (TMVI) is a small predicted neo-left ventricular outflow tract (LVOT). Simulation of the neoLVOT is time-consuming, requires multi-detector computerised tomography (MDCT), specialised software, and computer models of the prosthesis. Measurements that do not require neoLVOT simulation may provide...
New TMVI therapy to eliminate mitral regurgitation. Evidence and patient selection
26 Jun 2020 – From PCR e-Course 2020
Watch this video if you want to get the latest update on the first commercially available TMVI therapy (Tendyne), to learn about Tendyne clinical experience and how to identify the best candidates for this novel therapy.
Two-year outcomes of Tendyne Transcatheter Mitral Valve Implementation (TMVI) to treat symptomatic severe mitral regurgitation
Learn more about the 2-year outcomes of the first 100 patients treated as part of the Tendyne Expanded Clinical Study, and how the latest Tendyne clinical evidence may change the way the heart team treats mitral regurgitation.
Videos included on this page: the Hot Line presentation and...
Shaping care pathways for severe aortic stenosis patients in a COVID-19 context
Watch this roundtable discussion on the management of aortic stenosis in the context of the COVID-19 pandemic and how to readdress the treatment options and pathways to serve the needs of the patients in this difficult global crisis.
Portico FlexNav - Optimise TAVI outcomes from routine to complex cases
Watch this session if you want to learn how Portico enables you to achieve favorable haemodynamics and patient outcomes, to learn about the new Portico with FlexNav TAVI system and its deliverability and to learn the importance of looking ahead during transcatheter aortic valve implantation and...
Hot lines on Mitral interventions – part 1
25 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on mitral interventions presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: EVOQUE replacement, Tendyne TMVI, CLASP, V-i-V and V-i-R, Tendyne MAC.
PCR e-Course Hot lines on TAVI – part 1
25 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on TAVI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: Evolut Low-Risk trial, MyVal-1 study, BASILICA vs. control, non-invasive ultrasound therapy, long-term outcomes after V-i-V.
Hot lines on tricuspid interventions
Watch a series of Hot Lines on repair techniques for tricuspid regurgitation presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: Transferomal TTVR with EVOQUE, STTAR, TRILUMINATE.
PCR e-Course 2020 Late-Breaking Trials - part 2
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice:
- 2-year safety of revascularisation deferral based on iFR or FFR
- CABG and PCI in patients with CTO and multivessel disease
- Routine revascularisation vs. medical therapy
Stroke Prevention Day - Essentials in LAA closure
14 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about patient selection for LAA closure, the importance of TEE/CT imaging to identify LAA anatomy/morphology, and discover how to detect immediate/late complications and how to manage them, thanks to a selection of various challenging cases.
Stroke Prevention Day - PFO
14 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn how to build a stroke prevention team, what are the indications and pre-procedural screening of PFO closure, and discover the step-by-step procedure of PFO closure thanks to a selection of cases and studies.
Session for the Co-medicals in Japanese
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session dedicated to the co-medicals, to discover the nurse's perspective on percutaneous LAA closure, a study on the reduction of scattered radiation exposure in TAVI, and more!
